Ephedrine Abuse Among 36 Female Weightlifters

References

• Lake C R, Quirk R S. CNS stimulants and the look‐alike drugs. Psychiatr Clin North Am 1984; 7: 689–701
   PubMed Web of Science ®Google Scholar
• Miller M S, Millman R B, Gold M S. Amphetamines: pharmacology, abuse and addiction. Advances in Alcohol and Substance Abuse 1989; 8: 53–69
   PubMedGoogle Scholar
• Perkins R M, Williams M H. Effects of caffeine upon maximal muscular endurance of females. Med Sci Sports Exerc 1975; 7: 221–224
   Google Scholar
• Noakes T O, Gillies H. Drugs in sport (letter). S Afr Med J 1994; 84: 364
   Google Scholar
• Wadler G I, Hainline B. Phenylpropanolamine, ephedrine, and the “look‐alikes”. Drugs and the Athlete. FA Davis, Philadelphia, PA 1989; 101–106
   Google Scholar
• Segura J, Pascual J A, Ventura R, et al. International cooperation in analytical chemistry: experience in anti‐doping control at the Xlth Pan‐American Games. Clin Chem 1993; 39: 836–845
   Google Scholar
• Sidney K H, Lefcoe N M. The effects of ephedrine on the physiological and psychological responses to submaximal and maximal exercises in man. Med Sci Sports Exerc 1977; 9: 95–99
   Web of Science ®Google Scholar
• Nightingale S L. From the Food and Drug Administration (FDA report). JAMA 1996; 275: 1534
   Web of Science ®Google Scholar
• Grunding P, Bachman M. World Anabolic Review 1996. MB Muscle Books, Houston, TX 1995
   Google Scholar
• Duchaine D. Underground Body Opus: Militant Weight Loss and Recomposition. Clinical Studies: Phase 1, in Rx: 3x/Week LAAM Alternative to Methadone. NIDA Research Monograph Series. XIPE Press, Carson City, NV 1996
   Google Scholar
• Whitehouse A M, Duncan J M. Ephedrine psychosis rediscovered. Br J Psychiatry 1987; 150: 258–261
   PubMed Web of Science ®Google Scholar
• Roxanas M G, Spalding J. Ephedrine abuse psychosis. Med J Aust 1977; 2: 639–640
   PubMed Web of Science ®Google Scholar
• Loosmore S, Armstrong D. Do‐do abuse. Br J Psychiatry 1990; 157: 278–281
   Google Scholar
• Bruno A, Nolte K B, Chapin J. Stroke associated with ephedrine use. Neurology 1993; 43: 1313–1316
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Adverse events associated with ephedrine‐containing products, Texas, December 1993‐September 1995. MMWR 1996; 45: 689–693
   PubMedGoogle Scholar
• Food and Drug Administration. Dietary Supplements Containing Ephedrine Alkaloids. United States Department of Health and Human Services, Washington, DC June 4, 1997, Document No. 21 CFR Part III
   Google Scholar
• Johnston L, Bachman J, O'Malley P. Monitoring the future: continuing study of the lifestyles and values of youth. University of Michigan Institute for Social Research, Ann Arbor, MI 1990–1991
   Google Scholar
• Ross J, Winters F, Hartmann K, et al. 1988–89 Survey of Substance Abuse Among Maryland Adolescents. Maryland Department of Health and Mental Hygiene, Alcohol and Drug Abuse Administration, Baltimore, MD 1989
   Google Scholar
• Durant R H, Rickert V I, Ashworth C S, et al. Use of multiple drugs among adolescents who use anabolic steroids. N Engl J Med 1993; 328: 922–926
   PubMed Web of Science ®Google Scholar
• Tierney R, McLain L. The use of anabolic steroids in high school students. American Journal of Diseases of the Child 1990; 144: 99–103
   Google Scholar
• Radakovich J, Broderick P, Pickell G. Rates of anabolic‐androgenic steroid abuse among students in junior high school. J Am Board Fam Prac 1993; 6: 341–345
   PubMedGoogle Scholar
• Yesalis C E, Kennedy N J, Kopstein A N, et al. Anabolic‐androgenic steroid use in the United States. JAMA 1993; 270: 1217–1221
   PubMed Web of Science ®Google Scholar
• Pope H G, Jr, Katz D L, Hudson J I. Anorexia nervosa and “reverse anorexia” among 108 male bodybuilders. Compr Psychiatry 1993; 34: 406–409
   PubMed Web of Science ®Google Scholar
• Blouin A G, Goldfield G S. Body image and steroid use in male bodybuilders. Int J Eat Disord 1995; 18: 159–165
   PubMed Web of Science ®Google Scholar
• Andersen R E, Barlett S J, Morgan G D, et al. Weight loss, psychological, and nutritional patterns in competitive male body builders. Int J Eat Disord 1995; 18: 49–57
   PubMed Web of Science ®Google Scholar
• Drewnowski A, Kurth C L, Krahn D D. Effects of body image on dieting, exercise, and anabolic steroid use in adolescent males. Int J Eat Disord 1995; 17: 381–386
   PubMed Web of Science ®Google Scholar
• Yates A. Compulsive Exercise and Eating Disorders. Toward an Integrative Theory. Brunner/Mazel, New York 1991
   Google Scholar
• Chalmers J, Catalan J, Day A, et al. Anorexia nervosa presenting as morbid exercising. Lancet 1985; 1: 286–287
   PubMed Web of Science ®Google Scholar
• Furst D, Germone K. Negative addiction in male and female runners and exercisers. Percept Mot Skills 1993; 77: 192–194
   PubMed Web of Science ®Google Scholar
• Body Image, Eating Disorders, and Obesity: An Integrative Guide for Assessment and Treatment, J K Thompson. American Psychological Association, Washington, DC 1996
   Google Scholar
• Benson J E, Engelbert‐Fenton K A, Eisenman P A. Nutritional aspects of amenorrhea in the female athlete triad. Int J Sport Nutr 1996; 6: 134–145
   PubMedGoogle Scholar
• Grooms A M. The female athlete triad. J Fla Med Assoc 1996; 83: 479–481
   Google Scholar
• Nattiv A, Agostini R, Drinkwater B, et al. The female athlete triad. Clin Sports Med 1994; 13: 405–418
   PubMed Web of Science ®Google Scholar
• Skolnick A. “Female athlete triad” riskforwomen. JAMA 1993; 270: 921–923
   Web of Science ®Google Scholar
• Yurth E. Female athlete triad. West J Med 1995; 162: 149–150
   Google Scholar
• First M B, Spitzer R L, Gibbon M, et al. Structured Clinical Interview for DSM‐IV Axis I Disorders (SCID). New York State Psychiatric Institute, New York 1996
   Google Scholar
• American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders4th Edition. American Psychiatric Association, Washington, DC 1994
   Google Scholar
• Pope H G, Jr, Gruber A J, Choi P Y, et al. “Muscle dysmorphia:” an underrecognized form of body dysmorphic disorder. Psychosomatics 1997; 38: 548–557
   PubMed Web of Science ®Google Scholar
• Robins L N, Helzer J E, Weissman M M, et al. Lifetime prevalence of specific psychiatric disorders in three sites. Arch Gen Psychiatry 1984; 41: 949–958
   PubMed Web of Science ®Google Scholar
• Cooke D J, Allan C A. Self‐reported alcohol consumption and dissimulation in a Scottish urban sample. J Stud Alcohol 1983; 4: 617–629
   Google Scholar
• Swerdlow N R, Geyer M A, Perry W, et al. Drug screening in “normal” controls. Biol Psychiatry 1995; 38: 123–124
   PubMedGoogle Scholar
• Blynn S M, Gruder C L, Jegerski J A. Effects of biochemical validation of self‐reported cigarette smoking on treatment success and on misreporting abstinence. Health Psychol 1986; 5: 125–136
   Google Scholar